Natera stock: Third-quarter results set for November 5
Published on 10/29/2026 at 17:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming results and investor focus
- Natera will report on the quarter that ended September 30, 2026.
- The company will host a conference call shortly after releasing the figures.
- Recent clinical updates keep oncology evidence and test adoption in focus.
Natera announced on October 29, 2026, that it will release results for the third quarter ended September 30 after the market closes on November 5. The company published the schedule in a Natera company announcement.
Results date creates a clear catalyst
Natera said the release will be followed shortly by a conference call and webcast at 4:30 p.m. Eastern Time. The update will give investors a new set of operating figures before they reassess the company's growth trajectory and the outlook for its diagnostics portfolio.
The announcement does not provide third-quarter results or new guidance. It does, however, establish the next scheduled point at which investors can evaluate demand, test utilization and the financial impact of Natera's oncology, women's health and organ-health activities.
Clinical evidence remains in focus
The upcoming report follows a period of heavy attention on Natera's clinical programs. In its ESMO update, the company described data for its Signatera molecular residual disease technology across several cancer settings, including findings from the ICONIC and SAGITTARIUS studies. Natera said the data showed how serial circulating tumor DNA testing could inform recurrence monitoring and treatment decisions.
That research backdrop is relevant to the earnings event, but the company's October 29 announcement does not establish a revenue effect from the clinical presentations. Investors will therefore need to separate evidence development from measurable commercial adoption when the results arrive.
Quote moves above prior report
At Lang & Schwarz, Natera shares were quoted at EUR 382.40 on October 29, 2026, at 17:04:23 Berlin time. That was 3.20 percent above the EUR 370.55 quote recorded in our October 28 report, a fresh market change that qualifies this second main-values edition; it is separate from any Xetra daily comparison.
Investors can follow the real-time quote of Natera stock.
Natera, Inc. stock facts
- Company: Natera, Inc.
- ISIN: US6323071042
- Ticker: NTRA
- Primary exchange: Nasdaq
- Lang & Schwarz quote: EUR 382.40 on October 29, 2026, at 17:04:23 Berlin time
- 52-week range: USD 181.00 to USD 437.41
- Sector: Healthcare and medical diagnostics
Market context is available through the Nasdaq Composite market overview.
